Albireo Pharma Inc RSI
Что обозначает RSI в Albireo Pharma Inc?
RSI Albireo Pharma Inc является 68.03
Какое определение для RSI?
Индекс относительной силы (RSI 14) - это индикатор импульса, который сравнивает величину прибылей и убытков за определенный период времени для измерения скорости и изменения движений цены ценных бумаг.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI компаний в Health Care сектор на NASDAQ по сравнению с Albireo Pharma Inc
Что делает Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Компании с rsi похож на Albireo Pharma Inc
- US Masters Residential Property Fund имеет RSI из 68.01
- United Airlines имеет RSI из 68.01
- TXCOM Societe Anonyme имеет RSI из 68.02
- Tiaan Ayurvedic & Herbs имеет RSI из 68.02
- Hertz Global имеет RSI из 68.02
- PI Industries имеет RSI из 68.02
- Albireo Pharma Inc имеет RSI из 68.03
- Manulife имеет RSI из 68.04
- Zeta Global имеет RSI из 68.04
- Digicontent имеет RSI из 68.04
- Gowest Gold имеет RSI из 68.05
- CCUR имеет RSI из 68.05
- Concurrent Computer имеет RSI из 68.05